FIELD: organic chemistry, medicine.
SUBSTANCE: invention relates to using compounds of the general formula (I): 
and their pharmaceutically acceptable acid-additive salts. Compounds are used for preparing medicinal agents used in treatment diseases and state associated with system of adenosine receptors A2A, such as Alzheimer's disease, Parkinson's diseases, Huntington's syndrome, schizophrenia, anxiety state, pain, depression, narcomania to such substances as amphetamine, cocaine, opioides, ethyl alcohol, nicotine, cannabinoids, or in treatment of hypoxia, ischemia, epileptic attack. Also, proposed compounds exert neuroprotective effect and can be used as sedative, antipsychotic or anti-epileptic agents.
EFFECT: valuable medicinal properties of compounds.
18 cl, 1 tbl, 49 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BENZOTHIAZOL DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS | 2004 |
|
RU2351597C2 |
| OXADIAZOLES AS MUSCARINIC RECEPTOR AGONISTS M AND/OR M | 2019 |
|
RU2817018C2 |
| SPIRO-FUSED PIPERIDINE DERIVATIVES FOR APPLICATION AS INHIBITORS OF EXTERNAL MEDULLAR LAYER POTASSIUM CHANNEL | 2013 |
|
RU2642066C2 |
| BENZOTHIAZOLE DERIVATIVES | 2001 |
|
RU2251419C2 |
| 1,2,4-TRIAZOLONE DERIVATIVE | 2011 |
|
RU2566754C2 |
| AZABENZIMIDAZOLE COMPOUNDS AND A PHARMACEUTICAL COMPOSITION | 2019 |
|
RU2804485C2 |
| BENZOTHIAZOLE DERIVATIVES | 2005 |
|
RU2382782C2 |
| BENZOTHIAZOLE DERIVATIVES AND THEIR APPLICATION IN TREATMENT OF DISEASES RELATED TO ADENOSINE A RECEPTORS | 2004 |
|
RU2348622C2 |
| BENZOTHIAZOLE DERIVATIVES AND THEIR APPLICATION IN TREATMENT OF DISEASES RELATED TO ADENOSINE A RECEPTORS | 2004 |
|
RU2348629C2 |
| NOVEL CYCLOPENTANE DERIVATIVES | 2010 |
|
RU2572555C2 |
